Alphamab Oncology

Paige Launches AI Tool that Screens 505 Genes for Improved Cancer Diagnosis

AI startup Paige launched an AI-powered biomarker module that the company says can evaluate more than 505 genes and identify 1,228 molecular biomarkers from standard pathology slides.

By Katie Adams

BioPharma, Startups

China’s Alphamab raises $100M in Series A financing from US, Asian investors

The Suzhou-based firm plans to use the money to advance its therapies, currently in clinical development in China and Australia.

By Alaric DeArment